Opinion: [Withdrawal of Rimonabant - Walking the Tightrope of 21st Century Pharmaceutical Regulation?]

E-ISSN： 2212-3911|4|1|2-4

ISSN： 1574-8863

Source： Current Drug Safety, Vol.4, Iss.1, 2009-01, pp. : 2-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Walking the tightrope

By de Pedro Ricoy Raquel Howard Rosaleen Andrade Ciudad Luis

Target. International Journal of Translation Studies, Vol. 30, Iss. 2, 2018-01 ,pp. : 187-211

John Benjamins Publishing Company

Access to resources Recommend Favorite

The regulation of health professionals in the 21st century: Psychotherapy, cultural imperialism and the state

By Loewenthal Del

European Journal of Psychotherapy, Counselling & Health, Vol. 9, Iss. 2, 2007-06 ,pp. : 129-132

Routledge Ltd

Access to resources Recommend Favorite

The continuing saga - Basel II developments: liquidity regulation into the 21st century

By Leverick Phil

Balance Sheet, Vol. 12, Iss. 3, 2004-03 ,pp. : 9-14

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

UN-based biotechnology regulation: scientific and economic havoc for the 21st century

By Miller H.I.

Trends in Biotechnology, Vol. 17, Iss. 5, 1999-05 ,pp. : 185-190

Elsevier

Access to resources Recommend Favorite

Interpellative Sociology of Pharmaceuticals: Problems and Challenges for Innovation and Regulation in the 21st Century

By Abraham John Davis Courtney

Technology Analysis and Strategic Management, Vol. 19, Iss. 3, 2007-05 ,pp. : 387-402

Routledge Ltd

Access to resources Recommend Favorite